Biotech Breakthrough in Dry Mouth Relief: Murnia® Offers Novel Hydration Approach

NEW YORK, NY – November 20, 2025

A growing number of individuals suffer from persistent oral dryness, a condition linked to aging, medication side effects, and lifestyle factors. Now, a new biotechnology-based solution, Murnia® Mouth Spray, is poised to disrupt the dry mouth relief market with its innovative approach to hydration. Developed by Umayana and distributed through Young Innovations, Murnia® distinguishes itself from existing remedies by focusing on natural moisture delivery without relying on salivary stimulation.

The Rising Tide of Oral Dryness

Over 25 million Americans experience persistent oral dryness, a figure expected to rise with an aging population and increasing polypharmacy. This condition, clinically known as xerostomia, goes beyond discomfort. Prolonged dryness can lead to difficulties with speech, swallowing, taste perception, and significantly increases the risk of cavities, oral infections, and impaired quality of life. “Many patients are unaware that chronic dry mouth isn’t just a nuisance; it’s a gateway to more serious oral health problems,” explained one dental professional. Traditional treatments often involve artificial saliva substitutes or products designed to stimulate saliva production, but these can come with limitations and side effects. “Patients often find existing solutions offer only temporary relief or don't address the underlying issue of moisture imbalance,” a source stated.

Murnia’s Biotechnology-Based Approach

Murnia® Mouth Spray sets itself apart through a unique formulation built upon years of biotechnology research. The core of the product is a patented molecular compound derived from natural sources, combined with hyaluronic acid and betaine. This combination targets the root cause of dryness by delivering intense, sustained hydration directly to the oral tissues. Unlike traditional methods, Murnia® doesn’t aim to increase saliva, but rather to mimic the natural hydrating function of healthy oral tissues, effectively restoring moisture balance. “The beauty of this technology is its elegance,” said a researcher familiar with the product. “It’s not about forcing the body to do something it’s struggling to do, it’s about providing the building blocks for natural restoration.” The patented molecular compound, initially developed through research focused on wound care, is described as a standardized sesquiterpene-rich compound that plays a vital role in maintaining the oral water balance and protecting mucosal tissues.

Scientific Backing for Key Ingredients

The efficacy of Murnia® relies heavily on the established benefits of its key ingredients. Hyaluronic acid (HA) is a naturally occurring substance renowned for its exceptional water-holding capacity; it can retain up to 1000 times its weight in water. In the oral cavity, HA acts as a crucial component of the extracellular matrix, contributing to tissue hydration and aiding in the healing of mucosal damage. Betaine, derived from natural sources like sugar beets, functions as a humectant, attracting and retaining moisture, and protecting against irritation. Clinical trials have shown that betaine-containing oral care products can significantly relieve symptoms of dry mouth. Importantly, Murnia® utilizes naturally sourced betaine and is formulated to be free of alcohol and other potentially harmful ingredients, prioritizing patient safety and comfort. “The combination of these ingredients provides a synergistic effect, addressing multiple aspects of oral dryness,” explained a source. “It’s not just about adding moisture, it’s about protecting and restoring the natural barrier function of the oral tissues.”

Partnership and Market Strategy

The launch of Murnia® is a result of strategic collaboration between Umayana, the biotechnology innovator, and Young Innovations, a leading manufacturer and distributor in the oral healthcare industry. This partnership leverages Umayana’s scientific expertise with Young Innovations’ established distribution network, reaching dental professionals and patients across the country. CareQuest Innovation Partners played a key role in validating the product and accelerating its launch through their SMILE Health accelerator program, emphasizing the need for this advanced technology. The product is currently available through dental professionals, allowing for personalized recommendations and patient education. Furthermore, Murnia has been selected to participate in the CareQuest ACCELERATE program, which will help to reach 5,000 dental professionals through educational modules on the benefits of the product. This targeted approach aims to establish Murnia® as a trusted solution for managing persistent oral dryness and improving patient quality of life.